Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 04:10 PM EDT

Passage Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
37.57M 21.71M 34.6M 128.97M
Short-Term Investments
39.18M 92.58M 155.01M 186.81M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
463K 433K 4.27M 6.2M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
838K 923K 926K 1.73M
Total Current Assets
78.81M 117.96M 197.04M 325.07M
Property-Plant & Equipment
23.13M 32.15M 42.24M 23.81M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
23.6M 32.59M 46.51M 30.01M
Total Assets
102.41M 150.54M 243.55M 355.08M
Account Payables
742K 1.3M 4.07M 9.45M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
3.69M 3.37M 3.27M n/a
Other Current Liabilities
10.53M 5.26M 5.17M 661K
Total Current Liabilities
19.36M 16.34M 18.35M 29.5M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 6.92M
Total Long-Term Liabilities
21.79M 22.92M 23.83M 6.92M
Total Liabilities
41.15M 39.26M 42.18M 36.42M
Total Debt
25.48M 26.29M 27.11M n/a
Common Stock
6K 5K 5K 5K
Retained Earnings
-659.24M -594.47M -492.41M -356.28M
Comprehensive Income
8K -43K -966K -413K
Shareholders Equity
61.26M 111.28M 201.37M 318.66M
Total Investments
39.18M 92.58M 155.01M 186.81M